Particle.news
Health ❯ Healthcare ❯ Patient Care
Treatment Outcomes Chronic Illness Management Treatment Side Effects Chronic Conditions Treatment Efficacy Survival Rates Chronic Illness Treatment Options Post-Transplant Outcomes Symptom Management
If approved, the oral pan‑RAS pill would be the first broadly active KRAS inhibitor to meaningfully extend life for most patients with metastatic pancreatic cancer.
